Search

everythinglearnresearchcommunity

for

Search:↓

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Lower adiponectin levels are linked to higher insulin resistance in women with PCOS.

Iron deficiency is linked to hair loss in CTE patients.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Biotin deficiency is not a major cause of hair loss in women, so biotin supplements are not likely to be an effective hair loss treatment.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Every elderly patient had at least one skin condition, often linked to other diseases, highlighting the need for integrated skin and general healthcare in the elderly.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.